Announce Date | 06/13/2024 |
EPS Normalized Actual | $-0.83409 (Beat by $0.15591) |
EPS GAAP Actual | $-0.83409 (Beat by $0.15591) |
Revenue Actual | $0.12938B |
Revenue Surprise | Beat by $129.38M |
Announce Date | 07/29/2024 (Pre-Market) |
EPS Normalized Estimate | $-0.1 |
EPS GAAP Estimate | $-0.1 |
Revenue Estimate | $0.1640485B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Feb 2029 | 2.28 | 11.78 | 2.18171 | 2.39242 | 0 |
Feb 2028 | 3.22667 | 8.32 | 3.08757 | 3.38577 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2022 (May 2022) | 0.13 | 0.13 | 0.12938B | 35.91% | 129.38M |
FQ1 2022 (Jan 2022) | 2.15 | 2.15 | 0.196198B | 33.9% | 196.2M |
FQ4 2021 (Oct 2021) | 0.18 | 0.18 | 0.116678B | 35.94% | 116.68M |
FQ3 2021 (Aug 2021) | 0.56 | 0.56 | 0.102447B | 39.53% | 102.45M |
FQ2 2021 (Apr 2021) | 0.14 | 0.14 | 0.0829154B | 34.42% | 82.92M |
FQ1 2021 (Jan 2021) | 1.44 | 1.44 | 0.129678B | 28.92% | 129.68M |
FQ4 2020 (Nov 2020) | 0.00017024 | 0.00017024 | 0.074741B | 30.3% | 74.74M |
FQ3 2020 (Aug 2020) | -0.08 | -0.08 | 0.0619454B | 22.28% | 61.95M |
FQ4 Announce Date
07/29/2024 (Pre-Market)
Consensus EPS Estimates
-0.1
Consensus Revenue Estimates
0.1640485B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2026 (Feb 2026) | 2.33 | -- | 2.33 | 2.33 | 1 |
FQ4 2025 (Nov 2025) | 0.01 | -- | 0.00983258 | 0.01017443 | 1 |
FQ3 2025 (Aug 2025) | 0.16 | -- | 0.15732 | 0.16279 | 1 |
FQ2 2025 (May 2025) | -0.74 | -- | -0.75291 | -0.72761 | 1 |
FQ1 2025 (Feb 2025) | 2.16 | -- | 2.16 | 2.16 | 2 |
FQ4 2024 (Oct 2024) | -0.12 | -- | -0.12006 | -0.11994 | 0 |
FQ3 2024 (Jul 2024) | -0.1 | -- | -0.10005 | -0.09995222 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2026 (Feb 2026) | 0.29B | -- | 0.29B | 0.29B | 2 |
FQ4 2025 (Nov 2025) | 0.17B | -- | 0.17B | 0.18B | 1 |
FQ3 2025 (Aug 2025) | 0.17B | -- | 0.17B | 0.17B | 1 |
FQ2 2025 (May 2025) | 0.14B | -- | 0.14B | 0.14B | 1 |
FQ1 2025 (Feb 2025) | 0.27B | -- | 0.27B | 0.27B | 1 |
FQ4 2024 (Oct 2024) | 0.17B | -- | 0.17B | 0.17B | 0 |
FQ3 2024 (Jul 2024) | 0.16B | -- | 0.16B | 0.16B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (May 2022) | 0.13 | 0.13 | 100% | |
FQ1 2022 (Jan 2022) | 2.15 | 2.15 | 100% | |
FQ4 2021 (Oct 2021) | 0.18 | 0.18 | 100% | |
FQ3 2021 (Aug 2021) | 0.56 | 0.56 | 100% | |
FQ2 2021 (Apr 2021) | 0.14 | 0.14 | 100% | |
FQ1 2021 (Jan 2021) | 1.44 | 1.44 | 100% | |
FQ4 2020 (Nov 2020) | 0.00017024 | 0.00017024 | 100% | |
FQ3 2020 (Aug 2020) | -0.08 | -0.08 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (May 2022) | $0B | $0.13B | $129.38M | 100% |
FQ1 2022 (Jan 2022) | $0B | $0.2B | $196.2M | 100% |
FQ4 2021 (Oct 2021) | $0B | $0.12B | $116.68M | 100% |
FQ3 2021 (Aug 2021) | $0B | $0.1B | $102.45M | 100% |
FQ2 2021 (Apr 2021) | $0B | $0.08B | $82.92M | 100% |
FQ1 2021 (Jan 2021) | $0B | $0.13B | $129.68M | 100% |
FQ4 2020 (Nov 2020) | $0B | $0.07B | $74.74M | 100% |
FQ3 2020 (Aug 2020) | $0B | $0.06B | $61.95M | 100% |